Skip to main content

Table 3 Prevalence of genetic determinants associated with VRSA

From: RETRACTED ARTICLE: Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates

Subject

Sub group

No. studies

No. strains

Proportion (95% CI)

%Weight

P

I2

P sig

vanA

VRSA

34

181

0.71 (0.48, 0.89)

100

0

0.8515

0

vanB

VRSA

16

20

0.26 (0.05, 0.52)

100

0

0.6002

0

vanC1

VRSA

4

1

0.04 (0, 0.55)

100

0.21

0.3341

0.63

SCCmec II

VRSA

4

13

0.57 (0.33, 0.8)

100

0.58

0

0

SCCmec III

VRSA

2

3

0.17 (0.01, 0.43)

100

–

–

0.02

SCCmec IV

VRSA

6

14

0.39 (0.14, 0.67)

100

0.1

0.4635

0

  1. I2: the percentage of variance in a meta-analysis that shows study heterogeneity. VRSA: Vancomycin-resistant Staphylococcus aureus. MRSA: Methicillin-resistant Staphylococcus aureus